CgoaEWY7M_KELN2lAAAAABI_pbE809.png
SARS-CoV-2-IN-13 [56961-10-5]
T60919
Overview
- SupplierTargetMol Chemicals
- Product NameSARS-CoV-2-IN-13 [56961-10-5]
- Delivery Days Customer4
- Category SupplierChemical
- CertificationResearch Use Only
- Chemical NameSARS-CoV-2-IN-13
- Molecular FormulaC13H8Cl2N2O4
- Molecular Weight327.12
- Scientific DescriptionSARS-CoV-2-IN-13 (compound 5) is an analogue of niclosamide, displaying greater stability in human plasma and liver S9 enzymes assay. It improves bioavailability and half-life when administered orally and is a potent SARS-CoV-2 inhibitor with an IC50 of 0.057 microM [1].
- Shelf life instruction3 years
- SMILESOc1ccc(Cl)cc1C(=O)Nc1ccc(c(Cl)c1)[N+]([O-])=O
- Storage Instruction-20°C
- UNSPSC51202000
References
- Juang YP, et al. Design, synthesis and biological evaluations of niclosamide analogues against SARS-CoV-2. Eur J Med Chem. 2022 May 5;235:114295.Read more